Back

Effects of lorcaserin on the cardiometabolic risk factors in overweight or obese patients: a systematic review and meta-analysis

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Metabolic syndrome/Sleep apnea Obesity ESC Premium Access ESC Congress 2019

About the speaker

Photo
Ms Hsiao-Huai Kuo

Hsinchu (Taiwan)

14 More presentations in this session

Presentation thumbnail
Doctor M. Matangi (Kingston, CA)
Abstract Slides
Presentation thumbnail
Doctor N. Sasaki (Hiroshima, JP)
Abstract Slides
Presentation thumbnail
Professor D. Linz (Maastricht, NL)
Abstract
Presentation thumbnail
Professor K. Koh (Incheon, KR)
Abstract
Presentation thumbnail
Mr I. Stafeev (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Metabolic syndrome/Sleep apnea

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on blood pressure: a systematic review and meta-analysis
4 April 2025
thumbnail
Congress Presentation
Characteristics of overweight and obese patients undergoing a cardiac rehabilitation program.
20 March 2026
thumbnail
Congress Presentation
Efficacy and safety of direct oral anticoagulants versus warfarin in obese patients: a systematic review and meta-analysis of 31 studies
26 April 2024
thumbnail
Congress Presentation
Efficacy and safety of inclisiran monotherapy in patients with hypercholesterolemia without background lipid-lowering therapy: a systematic review and meta-analysis
24 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources